Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease

Vibration-Controlled Transient Elastography (VCTE) with Controlled Attenuation Parameter (CAP) is a widely used non-invasive technique for concomitant assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the level both of hepatic...

Full description

Bibliographic Details
Main Authors:	Sebastian Zenovia, Carol Stanciu, Catalin Sfarti, Ana-Maria Singeap, Camelia Cojocariu, Irina Girleanu, Mihaela Dimache, Stefan Chiriac, Cristina Maria Muzica, Robert Nastasa, Laura Huiban, Tudor Cuciureanu, Anca Trifan
Format:	Article
Language:	English
Published:	MDPI AG 2021-04-01
Series:	Diagnostics
Subjects:	NAFLD fibrosis steatosis CAP
Online Access:	https://www.mdpi.com/2075-4418/11/5/787

Similar Items

Nonalcoholic Fatty Liver Disease and Cardiovascular Diseases: The Heart of the Matter
by: Stefan Chiriac, et al.
Published: (2021-01-01)

Association between Nonalcoholic Fatty Liver Disease and Endocrinopathies: Clinical Implications
by: Ana-Maria Singeap, et al.
Published: (2021-01-01)

Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: A Bidirectional Relationship
by: Cristina M. Muzica, et al.
Published: (2020-01-01)

Nonalcoholic Fatty Liver Disease-Related Chronic Kidney Disease
by: Camelia Cojocariu, et al.
Published: (2020-01-01)

Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter
by: Giovanna Ferraioli, et al.
Published: (2017-05-01)

Liver-Specific Activation of AMPK Prevents Steatosis on a High-Fructose Diet
by: Angela Woods, et al.
Published: (2017-03-01)

Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients
by: Caroline Buss, R.D., Ph.D., et al.
Published: (2014-09-01)

Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes: Evaluation of Hepatic Fibrosis and Steatosis Using Fibroscan
by: Tran Thi Khanh Tuong, et al.
Published: (2020-03-01)

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)
by: Ziwen Wang, et al.
Published: (2020-06-01)

A Guide to Non-Alcoholic Fatty Liver Disease in Childhood and Adolescence
by: Jonathan L. Temple, et al.
Published: (2016-06-01)

Evolution of hepatic steatosis to fibrosis and adenoma formation in liver specific growth hormone receptor knockout (GHRLD) mice
by: Yong eFan, et al.
Published: (2014-12-01)

Clinical Impact of Small Bowel Capsule Endoscopy in Obscure Gastrointestinal Bleeding
by: Ana-Maria Singeap, et al.
Published: (2020-10-01)

Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
by: Eric Hajduch, et al.
Published: (2021-02-01)

Relationship between Serum Uric Acid Levels and Nonalcoholic Fatty Liver Disease in Non-Obese Patients
by: Alihan Oral, et al.
Published: (2019-09-01)

Combined effects of lifestyle risk factors on fatty liver index
by: Ulla Nivukoski, et al.
Published: (2020-04-01)

DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease
by: Stella Tommasi, et al.
Published: (2019-08-01)

Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease
by: Shan Li, et al.
Published: (2018-06-01)

The role of intestinal disbiosis in the development of mitochondrial dysfunction and nonalcoholic fatty liver disease
by: P. V. Seliverstov, et al.
Published: (2018-04-01)

Genetic variant I148M in <it>PNPLA3</it> is associated with the ultrasonography-determined steatosis degree in a Chinese population
by: Li Yiling, et al.
Published: (2012-11-01)

Validity of routine biochemical and ultrasound scores for prediction of hepatic fibrosis and steatosis in NAFLD
by: Rasha Eletreby, et al.
Published: (2021-05-01)

Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment
by: Annette Brandt, et al.
Published: (2017-09-01)

Nonalcoholic fatty liver disease in asymptomatic obese women(a)(a)The work was originated in the Biomedical Research Unit of The Mexican Social Security Institute at Durango, Mex.
by: Heriberto Rodriguez-Hernandez, et al.
Published: (2010-04-01)

Association of the <i>SH2B1</i> rs7359397 Gene Polymorphism with Steatosis Severity in Subjects with Obesity and Non-Alcoholic Fatty Liver Disease
by: Nuria Perez-Diaz-del-Campo, et al.
Published: (2020-04-01)

Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-Analysis
by: Abdulrahman Ismaiel, et al.
Published: (2021-07-01)

Predictors of non-alcoholic fatty liver disease in obese and overweight Egyptian children: Single center study
by: Hanaa M El-Karaksy, et al.
Published: (2011-01-01)

Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis
by: Maria Vulf, et al.
Published: (2021-09-01)

Secondhand Smoke Induces Liver Steatosis through Deregulation of Genes Involved in Hepatic Lipid Metabolism
by: Stella Tommasi, et al.
Published: (2020-02-01)

The preventive effect of liraglutide on the lipotoxic liver injury via increasing autophagy
by: Yini He, et al.
Published: (2020-01-01)

Detectability of Liver Steatosis and Fibrosis with Transient Elastography and Controlled Attenuation Parameter in Residents of St. Petersburg
by: V. P. Kovyazina, et al.
Published: (2021-04-01)

Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis
by: Lena Seidemann, et al.
Published: (2021-02-01)

The Effects of Foods on Blood Lipids in Non-alcoholic Fatty Liver Disease (NAFLD)—A Systematic Review and Meta-Analysis
by: Fredrik Rosqvist, et al.
Published: (2020-12-01)

Detection of patatin-like phospholipase domain-containing protein 3 in nonalcoholic fatty liver disease among egyptian patients
by: Kadry M El Saeed, et al.
Published: (2019-01-01)

The Impact of the COVID-19 Pandemic on Gastrointestinal Endoscopy Activity in a Tertiary Care Center from Northeastern Romania
by: Stefan Chiriac, et al.
Published: (2021-01-01)

The Influence of Dietary Fat on Liver Fat Accumulation
by: Charlotte J. Green, et al.
Published: (2014-11-01)

Shear wave rheometry with applications in elastography
by: Yengul, Sanjay S.
Published: (2019)

Hepatitis C Virus Prevalence and Risk Factors in a Village in Northeastern Romania—A Population-Based Screening—The First Step to Viral Micro-Elimination
by: Laura Huiban, et al.
Published: (2021-05-01)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
Published: (2006-04-01)

Liver steatosis in brain death donors
by: D. V. Voronov, et al.
Published: (2021-04-01)

The Circulating Micro-RNAs (−122, −34a and −99a) as Predictive Biomarkers for Non-Alcoholic Fatty Liver Diseases
by: Hendy OM, et al.
Published: (2019-12-01)

Effects of bile acid sequestration on hepatic steatosis in obese mice
by: Nancy Solís, et al.
Published: (2014-01-01)